Follow
Choi Taeyoung
Choi Taeyoung
VA St. Louis Health Care System (Biostatistician, Data Scientist)
Verified email at va.gov - Homepage
Title
Cited by
Cited by
Year
Association of treatment with nirmatrelvir and the risk of post–COVID-19 condition
Y Xie, T Choi, Z Al-Aly
JAMA Internal Medicine 183 (6), 554-564, 2023
2092023
Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in fall-winter 2022-2023
Y Xie, T Choi, Z Al-Aly
Jama 329 (19), 1697-1699, 2023
852023
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras
MD Yan Xie, Ph.D., Taeyoung Choi, M.S., and Ziyad Al-Aly
The New England Journal of Medicine, 2024
802024
Molnupiravir and risk of post-acute sequelae of covid-19: cohort study
Y Xie, T Choi, Z Al-Aly
bmj 381, 2023
792023
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study
Y Xie, T Choi, Z Al-Aly
The Lancet Infectious Diseases 24 (3), 239-255, 2024
542024
Nirmatrelvir and the risk of post-acute sequelae of COVID-19
Y Xie, T Choi, Z Al-Aly
MedRxiv, 2022.11. 03.22281783, 2022
472022
the risk of post-acute sequelae of COVID-19
Y Xie, T Choi, ZN Al-Aly
MedRxiv, 2022
302022
Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024
Y Xie, T Choi, Z Al-Aly
JAMA 331 (22), 1963-1965, 2024
162024
Data analysis using representation theory and clustering algorithms
S Alkhushayni, T Choi, D Alzaleq
WSEAS Trans. Comput 19, 310-320, 2020
102020
Mapping the effectiveness and risks of GLP-1 receptor agonists
Y Xie, T Choi, Z Al-Aly
Nature medicine, 1-12, 2025
12025
Adverse cardiovascular and kidney outcomes in people with SARS-CoV-2 treated with SGLT2 inhibitors
T Choi, Y Xie, Z Al-Aly
Nature Communications Medicine 4 (1), 179, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–11